PubMed COVID-19 Clinical Care

COVID-19 has changed many aspects of the hospitality and tourism industry, including technology-oriented and contactless solutions. Despite the increasing number of service companies using robots on their premises, most of the previous attempts and

Objective This study aims to survey medical students interested in ophthalmology about how changes in electives and Canadian Residency Matching Service (CaRMS) due to the novel coronavirus disease 2019 (COVID-19) pandemic have affected their

Recent controversies about wearing masks and getting vaccinated to slow the spread of coronavirus disease 2019 highlight the potential for individual rights and decision making to create widespread community-level outcomes. There is little work

Objective The coronavirus disease 2019 (COVID-19) pandemic has affected multiple areas of health care, including residency training programs. Elucidating the effect of the COVID-19 pandemic on resident clinical experience, surgical training, and

BACKGROUND: Demographic information has been shown to help predict high antibody titers of COVID-19 convalescent plasma (CCP) in CCP donors. However, there is no research on the Chinese population and little evidence on whole-blood donors. Therefore

CONCLUSIONS: The findings suggest that it is critical to advocate for and reinforce the public's understanding of the association between the increase in morbidity and the violation of restrictions preventing the transmission of viruses. Our findings

Objective The aim of the study is to describe an inexpensive and easily-constructed model eye for the purpose of teaching laser peripheral iridotomy (LPI) and selective laser trabeculoplasty (SLT) to ophthalmology residents. Methods Easily

No abstract

In this perspective article, we describe the vital need for a well-organized cancer registry in Romania, where lung cancer prevalence and mortality rates are alarmingly high. We discuss contributing factors such as increased use of chest X-rays and

There are very few small-molecule antivirals for SARS-CoV-2 that are either currently approved (or emergency authorized) in the US or globally, including remdesivir, molnupiravir, and paxlovid. The increasing number of SARS-CoV-2 variants that have